Business Development

The Oncology Nursing Society (ONS) is a professional organization of more than 35,000 members committed to promoting excellence in oncology nursing and the transformation of cancer care. As the main point of contact with patients and families, these nurses influence cancer care in all practice settings. ONS offers multiple ways to share your message with and engage this powerful community. Learn more about how a partnership with ONS can help you reach oncology nurses who are looking for education, products, and services that will help them improve cancer care.

Industry Supporters

Our nurse members, nurse scientists, and nurse teachers have become known as the standards bearers of advanced cancer care thanks to their dedication to deliver the best possible care, combined with their desire to advance evidence-based research.

Become part of the standard for quality oncology care. 

ONS Corporate Council and Industry Relations Panel

The ONS Corporate Council

The ONS Corporate Council is an exclusive, high-level opportunity available to a limited group of industry supporters. In the spirit of true partnership, it was created to reinforce your company’s industry leadership and recognize your essential role in advancing the oncology nursing profession.

Exclusive Benefits

  • High-level sponsor recognition at our national conferences, ongoing recognition and positioning in ONS communications, and year-round acknowledgement on the ONS website
  • ONS Corporate Council logo to help elevate your communication and promotional efforts
  • Key engagement opportunities with ONS executive leadership and ONS Board of Directors
  • Collaboration opportunities with other Corporate Council members and ONS
  • Priority updates and invitations to ONS sponsored events, ONS news, and ONS initiatives
  • Discounts and complimentary services

The investment for this fully integrated sponsorship opportunity is $140,000 per year.

For more information about the Corporate Council please contact for more information.

ONS Corporate Council Members


At AbbVie, we are committed to transforming standards of care for multiple blood cancers while advancing a dynamic pipeline of investigational therapies across a range of cancer types. Our dedicated and experienced team joins forces with innovative partners to accelerate the delivery of potentially breakthrough medicines. We are evaluating more than 20 investigational medicines in over 300 clinical trials across some of the world's most widespread and debilitating cancers. As we work to have a remarkable impact on people's lives, we are committed to exploring solutions to help patients obtain access to our cancer medicines. For more information, visit For clinical trial details: or

Amgen Oncology

At Amgen, we are committed to the relentless pursuit of breakthroughs for cancer patients and their families. Visit to learn more.

For more information on Amgen’s pipeline,

Clinical Trial specifics can be found at

Patient Assistance Programs include: and

AstraZeneca Pharmaceuticals LP

Bristol Myers Squibb

Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Our people are focused on helping millions of patients around the world in disease areas such as oncology, hematology, immunology, cardiovascular and neuroscience. Through the Bristol Myers Squibb Foundation, an independent 501(c)(3) charitable organization, we support community-based programs that promote cancer awareness, screening, care and support among high-risk populations in the United States, as well as China, Brazil and sub-Saharan Africa. Our employees around the world work every day to transform patients’ lives through science.

Eisai Inc.

At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to help address unmet medical needs. We are a fully integrated pharmaceutical business with discovery, clinical, and marketing capabilities. Our key areas of focus include oncology and neurology (dementia-related diseases and neurodegenerative diseases). To learn more about Eisai Inc., please visit us at and follow us on Twitter and LinkedIn. Also find out more about our Clinical Trials and Patient Assistance Program.

Genentech, Inc

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 40 years. Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world's leading biotech companies, with multiple products on the market and a promising development

G1 Therapeutics

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer. For additional information, please visit


Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit and follow @Incyte.

Janssen Pharmaceutical Companies of Johnson & Johnson

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension. Learn more at


Our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer worldwide. At Merck, the potential to bring new hope to people with cancer drives our purpose and supporting accessibility to our cancer medicines is our commitment. As part of our focus on cancer, Merck is committed to exploring the potential of immuno-oncology with one of the largest development programs in the industry across more than 30 tumor types. We also continue to strengthen our portfolio through strategic acquisitions and are prioritizing the development of several promising oncology candidates, with the potential to improve the treatment of advanced cancers.


Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 140 nationalities work at Novartis around the world. Learn more about our patient assistance program.

Pfizer Oncology

At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, genitourinary, colorectal, blood and lung cancers, as well as melanoma. Learn more about our patient assistance program.


Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases. Learn more about our patient assistance program.


Industry Relations Panel

Industry supporters may also join our new Industry Relations Panel, which offers two tiers of support at $50,000 and $25,000 per year. Please contact for more information. 

Industry Relations Panel members receive:

  • Recognition at our national conferences, ongoing recognition and positioning in ONS communications, and year-round recognition on the ONS website
  • Key engagement opportunities with ONS senior leadership
  • Collaboration opportunities with other Industry Relations Panel members and ONS
  • Discounts and complimentary services

Industry Relations Panel Members

Tier 2

Tier 1

Funding Opportunities

Sponsorship Opportunities

ONS offers promising opportunities to reach your target audience through our respected conferences, publications, podcasts, educational resources, awards, and member communications. Sponsorships offer an opportunity for your organization to support the needs of oncology nurses while providing essential financial support to ONS initiatives. Please contact the ONS Business Development Team at to learn more about how we connect you to our mission.

Advocacy Support

The ONS Center for Advocacy and Health Policy advocates for the advancement of quality cancer care. The Center elevates the voice of the oncology nurse and provides a forum for collaboration and advocacy at national and local levels. 

Program Support Opportunities

  • ONS Capitol Hill Days
  • ONS Policy Summits
  • ONS Chapter Advocacy Forums
  • ONS Congressional Briefings

Learn more about the ONS Center for Advocacy and Health Policy—2019 Initiatives.

Corporate Funding Priorities

ONS and its affiliated corporations seek corporate financial support for oncology nursing education and research programs, health policy initiatives, and communication to professionals and consumers. Corporate funding is guided by the ONS, Oncology Nursing Foundation, and Oncology Nursing Certification Corporation Corporate Support Position, and the Guiding Principles for ONS Policies Related to Corporate Support and Resolving Conflicts of Interest. It is also driven by priorities outlined in our strategic plan, research agenda, and health policy agenda.

Oncology Nursing Society Seal of Approval

Programs and materials submitted for the Oncology Nursing Society Seal of Approval are evaluated by ONS clinical experts, and must meet all review criteria for approval listed in the program guidelines, including consistency with ONS Standards and Guidelines and quality of the educational information. The Oncology Nursing Society Seal of Approval is a valuable symbol of recognition by one of the most respected organizations in cancer care.

ONS Standards and Guidelines provide the latest evidence-based information and guidelines to ensure the best possible outcomes at the highest levels of care. As a leading voice in oncology nursing, ONS is dedicated to providing these resources to nurses on the front line of cancer treatment and patient care.

Learn more or contact

Apply now for the Oncology Nursing Society Seal of Approval.



Licensing Opportunities

Provide your employees and customers with convenient, cost-effective access to hundreds of peer-reviewed articles, courses, publications, research resources, and other products. As a professional association of more than 39,000 members committed to promoting excellence in oncology nursing and the transformation of cancer care, ONS produces some of the most highly respected products in the field of nursing, including:

Licensing Options and Benefits

  • Reprints: Purchase customized, high-quality, professionally produced reprints of ONS journal articles, book chapters, and other content directly from ONS (50 reprint minimum). For more information, email
  • Translations: Translate and resell publications internationally. ONS books and journals are available to non-U.S. publishers for translation, including the right to publish, sell, and distribute foreign-language editions.
  • Integration: Purchase a license to incorporate ONS’s oncology-specific telephone triage protocols into your institution’s EMR or EHR system.
  • Customization: Licensing partners may customize ONS intellectual property for inclusion in your product, service, or other commercial endeavor.
  • Standards and guidelines: ONS standards and guidelines can be incorporated into your institution’s clinical practice or electronic health record system.
  • Core Competencies: Your organization can implement ONS-developed core competencies for a wide variety of oncology nursing roles.
  • Research Resources: Explore the possibility of using evidence-based resources to conduct research or for commercial purposes.
  • Accessibility: Your staff or customers will have immediate access to the licensed content at a centralized location.
  • Enhance Your Library: A site license will serve to supplement your electronic oncology nursing library.
  • Discounts: Purchase ONS products at a discount in bulk quantities, including books and online courses.
  • Your Ideas: ONS is interested in hearing your unique ideas related to a potential ONS licensing arrangement that would best serve your organization.

Take your nurses and institution to the next level. Learn how to engage with oncology experts to meet your organization's goals.

Contact Us

Email any questions you may have or to initiate a licensing partnership with ONS. Authors and others seeking limited, one-time permission to reprint content from an ONS resource should contact


Marketing and Advertising

Showcase your brand and reach a captive target audience with the below opportunities from ONS. 

List Rentals

One-time mailing lists are available to companies seeking to reach our members with information related to oncology nursing and quality cancer care.

ONS has a membership of more than 35,000 RNs and other healthcare professionals who are dedicated to excellence in patient care, education, research, and administration in oncology nursing. Please note that approximately 20–25% of members do not allow for their name and address to be included in the list rental database. As a result, the total number of names available for purchase is approximately 23,000–26,000.

Mailing List Rentals

The ONS mailing list is available to organizations who have relevant information for our oncology nurse membership. Visit the ONS List Rental page or contact InFocus Marketing at or 800-708-5478 for more information.

Print and Digital Advertising

Share your message with more than 35,000 ONS members plus a larger community of nurses who care for patients with cancer through print advertising, digital banner ads, interstitials, and more. For more information on advertising with ONS in 2021, please contact the Townsend Group, a subsidiary of SmithBucklin, or view the 2021 ONS Advertising Media Kit.

The Townsend Group
2001 K Street NW
3rd Floor North
Washington, DC 20006
Phone: 202.367.1116
Fax: 202.367.2173

Sales Contacts:
Companies 1-L
Liz Barrett

Companies M-Z
Kevin McDonnell

Digital advertising opportunities are available on our website, in select e-newsletters, on ONS Voice (our official news magazine), and on Clinical Journal of Oncology Nursing, and Oncology Nursing Forum (our scholarly journals).


Learn about our unique opportunities for face-to-face engagement with oncology nurses who are looking for education, products, and services that will help them improve cancer care.

Sponsorship Opportunities

    ONS Bridge® Virtual Conference
    September 2021

    ONS Bridge is a virtual conference designed to connect nurses to resources and education at their convenience through a mix of live and on-demand content. Occurring in September 2021, ONS Bridge will feature three days of top-notch educational sessions led by experts in the field. Virtual attendees will be able to earn approximately 30 NCPD contact hours, enjoy opportunities to network and learn at industry events, a virtual exhibit hall, and on-demand offerings.

    Email us to learn more about this exciting new annual event!

    46th Annual ONS Congress™
    April 20, 22, 27, and 29, 2021
    On-demand content available through May 27, 2021.

    The Annual ONS Congress brings 3,000 nurses together to learn about the newest treatments and symptom management strategies, expand their professional network, and advance their career. As the main point of contact with patients and their families, these nurses influence cancer care in all practice settings. 

    Learn about our unique opportunities to engage with oncology nurses who are looking for education, products, and services that will help them improve cancer care.

    Exhibit at ONS Congress: Make your plans now to meet with oncology nurses who are leaders on the frontline of cancer care. Share how you can help them provide better patient care, advocate for their patients, take the next step in their career, or take care of themselves so they can be the best nurse they can be. Our learning hall is filled with partners from industry, patient advocacy groups, employers, recruiters, and more. Join this group of oncology leaders who support oncology nurses and improve patient care. 

    Become a Sponsor: Put your name and logo in front of thousands of oncology nurses and others in the oncology field through ONS Congress sponsorship opportunities. ONS Congress gives you the visibility you need to put your organization front and center. Whether your goal is to increase brand recognition, drive traffic to your booth, or send your company’s message home with each attendee, you will find what you need to meet your goals at ONS Congress. We have a variety of new opportunities available, but if you don’t see what you’re looking for, contact us about creating a custom package to help you make the greatest impact.

    Hold an Event: Holding an event at ONS Congress connects you to the nurses who are the main point of contact for patients with cancer and their loved ones. They manage the symptoms of cancer and its treatment, provide patient education, and serve as a consistent point of communication and care throughout the cancer continuum.

    • Symposia Events: Host a breakfast, lunch, or dinner presentation to share valuable knowledge with attendees, while providing them with the opportunity to network with other nurses. Symposia can offer NCPD or be informational.
    • Theater Presentations: Take advantage of this opportunity to offer non-NCPD presentations to attendees during learning hall time.
    • Ancillary Events and Meeting Space: Find out how you can hold a smaller event or set aside space for internal staff meetings or speaker ready rooms.

    Email us to learn more and book your event today!

    Funding for Awards

    Each year, ONS grants prestigious recognition to oncology nurses, researchers, and employers who change lives and better their profession. These awards are made possible through the generous support of our industry partners.

    ONS Awards

    ONS is dedicated to the professional development of oncology nurses around the world through a renowned awards program.

    • ONS Distinguished Awards recognize oncology nurses who have made outstanding contributions to ONS and the oncology nursing profession on a national level. These nurses are recognized at Congress opening ceremonies and throughout the year. The annual commitment for each of the four awards is $5,000. 
    • The International Award for Contributions in Cancer Care recognizes a nurse who has contributed to the improvement of cancer care in a country outside the United States. The annual commitment is $8,500.
    • ONS Excellence Awards recognize ONS members for their unique contributions within their field of expertise. The annual commitment for each of the 11 awards is $1,500.